Post navigation
Previous Post
Physiological Reviews: Vasopressin V1a and V1b receptors: From molecules to physiological systems
Next Post
Biomedicine & Pharmacotherapy: Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist
Related Posts